Aurora Cannabis Inc.

Aurora Cannabis Inc.

ACB
Aurora Cannabis Inc.US flagNASDAQ Global Select
2.68
USD
+0.00
- -
165.70MMarket Cap
Aurora Cannabis Inc.
ACB
(NASDAQ Global Select)

Recent

price

2.68

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2024
2025
2026
TTM
FRC
- -
- -
- -
- -
- -
- -
1.34
7.77
14.41
30.64
27.55
14.5
10.3
6.24
5.27
- -
5.68
Revenue per Share
-0.36
-2.12
-2.38
-2.95
-13.55
-14.85
-5.32
-5.58
18.77
-36.63
-336.57
-41.01
-79.92
-1.6
0.03
- -
-2.41
Basic EPS, GAAP
-0.53
-2.08
-2.11
-3.35
-25.17
-17.4
-8.05
-16.81
-57.06
-75.69
-70.84
-15.59
-6.63
-1.97
0.02
- -
-0.64
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
-2.97
-4.69
6.8
3.88
11.48
0.14
0.22
83.01
405.63
547.51
224.47
124.36
33.33
13.96
11.37
- -
10.01
Book Value per Share
13.91
10.37
8.11
5.2
13.15
5.98
5.55
63.11
154.47
65.71
80.29
46.27
27.53
11.98
9.48
- -
8.04
Tangible Book Value per Share
- -
- -
- -
- -
- -
1
1
2
4
8
10
17
21
43
55
- -
56
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
1
18
55
246
269
245
221
270
289
321
321
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
-318.97
-53.36
-145.13
-122.61
-171.83
-100.57
-99.11
-11.52
3.61
-14.55
-14.45
Operating Margin (%)
- -
- -
- -
- -
- -
- -
1
1
12
88
115
98
94
33
13
14
14
Depreciation Expense
- -
- -
- -
- -
-2
-10
-6
-13
72
-294
-3,283
-694
-1,718
-69
2
-136
-136
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
10.47
- -
- -
- -
- -
- -
13.56
- -
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
-397.71
-71.78
130.33
-119.54
-1,221.68
-282.82
-776.02
-25.71
0.55
-42.41
-42.41
Profit Margin (%)
2
1
1
1
-2
-6
-3
170
145
224
145
550
614
302
367
331
331
Working Capital
- -
- -
- -
- -
- -
2
4
64
201
395
379
359
236
48
78
18
18
LT Debt
2
1
1
1
2
4
6
219
1,553
4,387
2,123
2,038
662
602
609
512
512
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
-7.03
- -
- -
- -
- -
- -
1.26
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
8.44
- -
- -
- -
- -
- -
0.5
- -
- -
Return on Capital (%)
- -
- -
- -
-55.45
-176.7
-1,163.49
-3,542.85
-13.42
8.23
-9.88
-99.84
-32.32
-121.84
-10.51
0.26
-22.88
-22.88
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Sep'26
Dec'26
Mar'26
ST Debt
65
68
6
LT Borrowings
- -
- -
- -
LT Finance Leases
35
33
18
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
57
57
59
Market Capitalization
464
327
257

Working Capital

FRC

in mil. unless spec.
Sep'26
Dec'26
Mar'26
Total Current Assets
424
446
397
Cash, Cash Equivalents & STI
96
108
117
Accounts Receivable, Net
47
44
42
Inventories
222
231
175
Total Current Liabilities
124
146
67
Payables & Accruals
56
74
58
ST Debt
65
68
6
Deferred Revenue
1
2
1

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
427.25%
-19.09%
-15.9%
Free Cash Flow
-315.67%
-827.28%
-3,887.39%
Net Income, GAAP
-883.29%
-1,755.06%
-8,645.82%
Sales/Revenue/Turnover
- -
4.29%
10.97%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
63
64
67
75
270
2025
83
81
88
91
289
2026
98
90
94
38
321

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.01
-0.36
- -
-0.76
-1.6
2025
0.1
-0.22
0.52
- -
0.03
2026
-0.27
-0.91
0.03
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Business
Aurora Cannabis Inc. produces and distributes medical and consumer cannabis products worldwide from its headquarters in Edmonton, Alberta, Canada, where the company was founded in 2006. The company offers pharmaceutical-grade cannabis including dried flower, oils, extracts, capsules, pre-rolls, vapes, edibles, concentrates, and topicals under brands such as Drift, San Rafael '71, Daily Special, Tasty's, MedReleaf, CraftPlant, Farm Gas, and Sourdough; it also provides patient counseling, outreach services, and plant propagation through its controlling interest in Bevo Farms Ltd., with operations spanning Canada, Europe (including Germany, Poland, and Denmark), Australia, Latin America, and other international markets. Aurora Cannabis operates through Canadian cannabis and plant propagation segments, focusing on GMP-certified production for medical patients and premium adult-use consumers while leveraging advanced cultivation facilities and a hybrid manufacturing network that incorporates third-party supply. In recent developments, Aurora Cannabis expanded its partnerships with a three-year $27 million supply agreement with SNDL Inc. for premium flower from New Brunswick, strengthening its hybrid manufacturing strategy following record growth in international medical cannabis; the company launched its first German-grown products with Demecan and highest-THC medical offerings in Poland, including Farm Gas (27% THC) and Sourdough (29% THC); it announced a distribution partnership with Leafio Australia to broaden access for brands like MedReleaf and CraftPlant after acquiring MedReleaf Australia in February 2024; and introduced innovative medical cannabis-infused ready-to-drink beverages like VACAY's Strawberry Pineapple Tropical Soda for veteran patients.

Company News

APIChatGPT
  • ACB Stock Down 28% in Three Months: Time to Buy the Dip or Cash Out?

  • Aurora Named to TIME Canada's Best Companies 2026 List

  • Aurora Cannabis Inc. Announces Filing and Mailing of the Management Information Circular in Connection with the Annual General Meeting of Shareholders

  • Aurora Q4 Earnings Call Flags Reset Year as Canada Pressure Weighs

  • Aurora Cannabis: Weak Near-Term Outlook But Too Cheap To Ignore - Buy

  • Aurora Cannabis Q4 Earnings Call Highlights

  • Aurora Cannabis Announces Full Year and Fiscal 2026 Fourth Quarter Results with Record Annual Revenue and Adjusted EBITDA¹

  • Wall Street Week Ahead

  • Aurora Deepens its Impact for Veterans Across Canada

  • Aurora Cannabis to Host Fourth Quarter and Fiscal Year 2026 Investor Conference Call and File Related Year End Information

  • Top Canadian Marijuana Stock Choices For Better Investing In 2026

  • Aurora Granted Plant Breeders' Rights, Strengthening Leadership in Cannabis Science

  • Aurora Advances Global Medical Cannabis Portfolio with New Product Launches Across Key International Markets

  • Aurora Cannabis: Why I Like This Stock

  • Finally. Marijuana Gets Reclassified, but Are Pot Stocks Still Too Risky?

  • Aurora Cannabis Accelerates Global Medical Cannabis Leadership with Accretive Acquisition of Safari Flower Company, Expanding EU GMP Capacity to Serve Growing High Margin International Markets

  • Cannabis Stock ACB Down 19% YTD: Should You Buy the Dip?

  • 3 Canadian Cannabis Stocks Ready for Potential Breakouts in April 2026

  • Aurora Recognized for Executive Gender Diversity by the Globe & Mail for Second Consecutive Year

  • Top Canadian Marijuana Stocks To Watch This Month For Better Trading